losartan has been researched along with Metastase in 3 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Excerpt | Relevance | Reference |
|---|---|---|
| "Losartan inhibits NHE1 activity and the migration of human melanoma cells." | 7.88 | The Angiotensin II Type 1 Receptor Antagonist Losartan Affects NHE1-Dependent Melanoma Cell Behavior. ( Hofschröer, V; Nielsen, N; Olschewski, DN; Schwab, A; Seidler, DG; Stock, C, 2018) |
| "Tumor metastasis would seriously impair the efficacy of chemotherapy." | 5.43 | Suppression for lung metastasis by depletion of collagen I and lysyl oxidase via losartan assisted with paclitaxel-loaded pH-sensitive liposomes in breast cancer. ( Cun, X; Gao, H; He, Q; Lu, L; Wang, Y; Xia, T; Yang, Y; Yu, Q; Zhang, L; Zhang, Q; Zhang, Z, 2016) |
| "Losartan inhibits NHE1 activity and the migration of human melanoma cells." | 3.88 | The Angiotensin II Type 1 Receptor Antagonist Losartan Affects NHE1-Dependent Melanoma Cell Behavior. ( Hofschröer, V; Nielsen, N; Olschewski, DN; Schwab, A; Seidler, DG; Stock, C, 2018) |
| "Tumor metastasis would seriously impair the efficacy of chemotherapy." | 1.43 | Suppression for lung metastasis by depletion of collagen I and lysyl oxidase via losartan assisted with paclitaxel-loaded pH-sensitive liposomes in breast cancer. ( Cun, X; Gao, H; He, Q; Lu, L; Wang, Y; Xia, T; Yang, Y; Yu, Q; Zhang, L; Zhang, Q; Zhang, Z, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olschewski, DN | 1 |
| Hofschröer, V | 1 |
| Nielsen, N | 1 |
| Seidler, DG | 1 |
| Schwab, A | 1 |
| Stock, C | 1 |
| Zhang, L | 1 |
| Wang, Y | 1 |
| Xia, T | 1 |
| Yu, Q | 1 |
| Zhang, Q | 1 |
| Yang, Y | 1 |
| Cun, X | 1 |
| Lu, L | 1 |
| Gao, H | 1 |
| Zhang, Z | 1 |
| He, Q | 1 |
| Arnold, SA | 1 |
| Rivera, LB | 1 |
| Carbon, JG | 1 |
| Toombs, JE | 1 |
| Chang, CL | 1 |
| Bradshaw, AD | 1 |
| Brekken, RA | 1 |
3 other studies available for losartan and Metastase
| Article | Year |
|---|---|
The Angiotensin II Type 1 Receptor Antagonist Losartan Affects NHE1-Dependent Melanoma Cell Behavior.
Topics: Angiotensin II Type 1 Receptor Blockers; Cell Line, Tumor; Cell Movement; Humans; Losartan; Melanoma | 2018 |
Suppression for lung metastasis by depletion of collagen I and lysyl oxidase via losartan assisted with paclitaxel-loaded pH-sensitive liposomes in breast cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Collagen Type I; Drug Delivery Systems; Hydrogen-Ion Co | 2016 |
Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Disease Progression; Extracellular Matrix; Losarta | 2012 |